Shell Cross-Linked Nanoparticles Designed To Target Angiogenic Blood Vessels via αvβ3 Receptor−Ligand Interactions
- 27 August 2004
- journal article
- Published by American Chemical Society (ACS) in Macromolecules
- Vol. 37 (19), 7109-7115
- https://doi.org/10.1021/ma048824e
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α v β 3 -Integrin–Targeted NanoparticlesCirculation, 2003
- Influence of Targeting Ligand Flexibility on Receptor Binding of Particulate Drug Delivery SystemsBioconjugate Chemistry, 2003
- Recent advances in angiogenesis, anti-angiogenesis and vascular targetingTrends in Pharmacological Sciences, 2002
- Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alterationJCI Insight, 2002
- Design of Dendritic Macromolecules Containing Folate or Methotrexate ResiduesBioconjugate Chemistry, 1999
- Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin geneNature Biotechnology, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imagingNature Medicine, 1998
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998
- Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation timesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993